NORDISK GRUPPE

1
NORDISK GRUPPE
2
Hvor vanlig er ADHD i Europa?
Prevalensen ligger mellom 1.8 16.6
Prevalence rates range between 1.8 16.6
(EINAQ 2003)
3
Hyppighet i verden
Prevalens mellom 4 12
(NAAAC 2002)
4
Beregnet prevalens for Norge 18 år (N 3 442
579)
5
Hva sier forskningen om voksne med ADHD?

• Ingen diagnosekriterier for voksne
• Data fra diverse oppfølgingsstudier kan vanskelig
  sammenlignes, fordi diagnosekriteriene har blitt
  forandret underveis og gruppene ofte har vært
  selekterte
• MTA studiens resultater kan ikke uten videre
  overføres til en voksenpopulasjon

6
FRA 1997 TIL 2003
7
KJØNN OG ALDER
8
VURDERINGER
9
AVSLAG GITT FORDI(n622)
10
HVORFOR FRARÅDET
11
HVILKE MEDISINER?
12
ANTALL MEDISINERT

• 262 (20) har brukt medisiner i to år eller mer.
  Disse handler rapporten om
• 1066 (80) startet med medisiner og
• 526 pasienter brukte medisiner
• 411 hadde autoseponert
• 129 Usikker ( mangl. innrapportering)

13
SEPONERT FORDI
14
PASIENT KARAKTERISTIKA
15
KARAKTERISTIKA FORTS
16
TILLEGGSPROBLEMER N262
17
BIVIRKNINGER
18
Mestring og fungering i forhold til
19
Alder
20
MEDSINENS VIRKNING
21
ÅRLIG KJØRELENGDE
Kvinner 12,7 menn 17,7
22
ANTALL ULYKKER SISTE 3 ÅR
23
(No Transcript)
24
evt.kommentar
Sikkerhetsbelte
57.1
Mobiltelefonbruk
4.8
Skjedde før medisinering
4.8
GLEMT FØRERKORT
4.8
Pas.på moped
9.5
Kommentar
9.5
Kjørte i kollektivfelt
4.8
Teknisk mangel på bil
4.8
0
10
20
30
40
50
60
25
Førerkorttype og yrkessjåfør
26
RELATIV RISIKO VED
27

• A Age
• S Sex
• O Occupation
• OD Other diseases/medical condition
• M Mileage
• MS Mental status
• L Age of licence
• R Place of residence
• E Ethnic group
• D Alcohol use
• RTM Regression (towards the mean)

• I Co-morbidity
• Y Education
• W Marital status
• ToD Time of day
• DoW Day of week
• LOC Location
• BMI Body mass index
• VRD Visual refraction disorders
• SS Sleep schedule
• ASL Average standard of living
• MERMother emotional responsiveness (1 ADHD study
  only)
• PCParental changes (1 ADHD-study only)

28
ADHD WORLD

• KNOWING ME KNOWING YOU
• STOCKHOLM
• ROMA
• BARCELONA
• AMSTERDAM
• ADHD WORLD GROUP
• PARIS?

29
THE EXECUTIVE COMMITTEE

• Mary Durheim USA
• Carol Mairs, Canada
• Regina van Criekinge, Nederland
• Cristiane d Angelo, Brasil
• Mark Brandtman, Australia
• Brigit Solomon , UK
• Knut Halvard Bronder, Norge
• Dion Kobussen, NL
• Paulo Mattos, Brasil

30
The Global Network exists to improve the quality
of life of those who may be affected by ADHD

• Supporting the leadership of ADHD advocacy
  groups, by
• Establishing an electronic communication forum
• Hosting global ADHD leadership meetings
• Fra Denver

31

• Assuring ADHD is a recognized and treated
  condition, globally, by
• Promoting evidence-based practices in medicine,
  education, nursing, social work
• Empowering advocacy and professional groups
  within the Global Network with appropriate,
  science-based information
• Finalizing and adopting a Global Principles
  Statement/Declaration of Rights.

32

• Positive information setting, get rid of the
  'Americanisation'
• Carefully include and address the diversity and
  cultural issues, not to be seen as 'middle-class,
  white' problem.
• Stick to science and evidence
• Importance of making information available to
  everyone
• Empathy and understanding has to be evident to
  all classes and groups.

33

• Spread support, act like a 'clearing house'
• Give out verified information
• Provision of info in more than 1 language,
  although the universally used language will be
  English in any communication
• The group also needs to be taking part in other
  initiatives such as EINAQ, which is a European
  initiative developing a teaching package
  guideline for adults in the whole of Europe.
  Equally good initiatives are taking place
  elsewhere and we need to gather that, verified,
  information.
• Transparency is of pivotal importance, as is
  impartiality